Delivery Order SPE2DB20D3103-SPE2DB24FM4N2
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $179K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, with ID SPE2DB22D1002|SPE2DB25FLBW3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a ceiling value of $4,592.35. This is a firm fixed-price delivery order contract with a completion date of May 8, 2025. The contract is not set-aside and is open to competition. Amerisourcebergen Drug Corp is the prime...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB24FZ31Y, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Dupixent 300 mg/2 ml pen 2 ml. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,957.05 and a completion date of December 19, 2023. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pen 2 ml. The contract has a total ceiling value of $12,052.57 and an ultimate completion date of December 20, 2023. The contract is a Delivery Order type with a Firm Fixed Price pricing structure. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award, with ID SPE2DB20D2200|SPE2DB25FW77F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a ceiling value of $14,460.73 and a completion date of April 22, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation,...
- This federal contract award, valued at $11,796.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Dupixent 300 mg/2 ml pen, with an ultimate completion date of April 22, 2025. This award is a delivery order, with a firm fixed-price pricing type, and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, with ID SPE2DB25D3017|SPE2DB25FVHTK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Dupixent 300 mg/2 ml pens. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $10,584.78 and a performance period extending through April 17, 2025. The contract is not set-aside and was awarded as part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM6C6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of Dupixent 300 mg/2 ml pens with an ultimate completion date of February 9, 2024 and a ceiling value of $171,611.43. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,652.35 delivery order contract is for the supply of Dupixent 200 mg/1.14 ml pen medical products. The contract has an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award, with ID SPE2DB20D1109|SPE2DB23FP56Z, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,568.02 delivery order is for the drug Dupixent 300 mg/2 ml pen, with a completion date of July 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,577.17, is for the delivery of Dupixent 300 mg/2 ml pen (2 ml) and has an ultimate completion date of April 24, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...